News
We recently published a list of 21 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Novo ...
6h
Zacks Investment Research on MSNWhy Novo Nordisk (NVO) is a Top Momentum Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
--The company currently guides for 16%-24% sales growth at constant exchange rates and for 19%-27% operating profit growth. "With the continued weak trends in the U.S. continuing into 2Q, we now ...
By Sukriti Gupta (Reuters) -European shares were little changed on Monday, as investors awaited details on the U.S.-China ...
The Food and Drug Administration accepted Novo Nordisk’s marketing application for an oral version of its weight-loss drug Wegovy and will decide in the fourth quarter, the Danis ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...
Euroclear plans to seize and redistribute about 3 billion euros ($3.4 billion) of Russia's funds that are frozen at the ...
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...
Volkswagen on Friday said its first-quarter operating profit for the core brand group, which includes its best-selling VW brand, declined by 46.3%, impacted by EU carbon provisions and write-downs on ...
Denmark's biggest lender Danske Bank reported forecast-beating first-quarter profits on Friday and said it expects the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results